...Before joining Axcella last year, King-Jones was lead commercial counsel at Sarepta Therapeutics Inc. (NASDAQ:SRPT). NervGen Pharma Corp....
...Inc. Elizabeth S. Eaton, Staff Writer Ultragenyx Pharmaceutical Inc. MiMedx Group Inc. Iveric bio Inc. Agios Pharmaceuticals Inc. Ardelyx Inc. Axcella Health Inc. NervGen Pharma Corp. Novo...

...3/27/19 $173.0 $371.9 $565.8 52% BioLASCO Taiwan Co. Ltd. (TPEx:6662) 3/26/19 $2.5 $30.6 $35.7 17% NervGen Pharma Corp....

...spinal cord injury and peripheral nerve injury and begin a Phase I trial in 2020. NervGen Pharma Corp....
...acute myocardial infarction (MI), multiple sclerosis, stroke and Alzheimer’s disease. Mary Romeo, Staff Writer Case Western Reserve University NervGen Pharma Corp. Jerry...